Trademark: 88980899
Status Date
Tuesday, June 22, 2021
Registration Number
6393041
Registration Date
Tuesday, June 22, 2021
Filing Date
Tuesday, April 21, 2020
Published for Opposition
Tuesday, August 18, 2020
5 Pharmaceuticals for the treatment of neurological and metabolic related diseases and disorders; pharmaceutical preparations and substances for the treatment of cognitive disorders
42 Research and development services in the field of dosage forms for extended release pharmaceuticals
The mark consists of a stellate design inside an octagon.
Color is not claimed as a feature of the mark.
Jan 4, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Jan 4, 2024
Teas Change Of Correspondence Received
Jan 4, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 4, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 22, 2021
Registered-Principal Register
May 21, 2021
Notice Of Reinstatement E-Mailed
May 18, 2021
1(B) Basis Deleted; Proceed To Registration
Apr 13, 2021
Notice Of Allowance Cancelled
Dec 10, 2020
Reinstatement Granted - Request To Delete 1(B) Filed
May 17, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
May 17, 2021
Abandonment - No Use Statement Filed
Mar 10, 2021
Notice Of Design Search Code E-Mailed
Mar 9, 2021
Divisional Processing Complete
Dec 10, 2020
Divisional Request Received
Jan 11, 2021
Case Assigned To Intent To Use Paralegal
Dec 10, 2020
Teas Request To Divide Received
Oct 13, 2020
Noa E-Mailed - Sou Required From Applicant
Aug 18, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 18, 2020
Published For Opposition
Jul 29, 2020
Notification Of Notice Of Publication E-Mailed
Jul 14, 2020
Approved For Pub - Principal Register
Jul 14, 2020
Assigned To Examiner
Apr 30, 2020
Notice Of Design Search Code E-Mailed
Apr 29, 2020
New Application Office Supplied Data Entered
Apr 24, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
